Skip to main content
Premium Trial:

Request an Annual Quote

Squibb Licenses Pangea Computational Tools to Boost Genomics Effort

Premium

OAKLAND, Calif.--Bristol-Myers Squibb has licensed from Pangea Systems here state-of-the-art computational tools that will allow faster and more accurate clustering and alignment of expressed sequence tags (EST's) and full-length sequences within large public and proprietary databases. Pangea said the tools will provide Squibb with accurate molecular information in order to increase the sensitivity with which molecular targets can be identified and the selectivity with which they can be validated for use in the drug discovery process.

"Some of the computational challenges of proteomics, expression profiling, and sequence datamining can be reasonably approached only if we can reduce the complexity and redundancy of large EST databases," commented Wes Cosand, Squibb's director of genomic technology. He called the Pangea tool "an excellent package for performing this task."

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.